Management of polyomavirus-associated nephropathy in renal transplant recipients.
about
The miRNA world of polyomavirusesHuman polyomavirus reactivation: disease pathogenesis and treatment approachesReduced tumorigenicity and pathogenicity of cervical carcinoma SiHa cells selected for resistance to cidofovirCommon exposure to STL polyomavirus during childhoodA cornucopia of human polyomaviruses.BK viremia and polyomavirus nephropathy in 352 kidney transplants; risk factors and potential role of mTOR inhibition.Structural Based Analyses of the JC Virus T-Antigen F258L Mutant Provides Evidence for DNA Dependent Conformational Changes in the C-Termini of Polyomavirus Origin Binding Domains.Sequence Variation in Amplification Target Genes and Standards Influences Interlaboratory Comparison of BK Virus DNA Load Measurement.New Structural Insights into the Genome and Minor Capsid Proteins of BK Polyomavirus using Cryo-Electron MicroscopyPossible antiviral effect of ciprofloxacin treatment on polyomavirus BK replication and analysis of non-coding control region sequences.High-level viruria as a screening tool for BK virus nephropathy in renal transplant recipientsBK Polyomavirus Replication in Renal Tubular Epithelial Cells Is Inhibited by Sirolimus, but Activated by Tacrolimus Through a Pathway Involving FKBP-12.Characterization of Immunodominant BK Polyomavirus 9mer Epitope T Cell Responses.Brincidofovir for polyomavirus-associated nephropathy after allogeneic hematopoietic stem cell transplantation.Alloimmunity But Not Viral Immunity Promotes Allograft Loss in a Mouse Model of Polyomavirus-Associated Allograft Injury.Caveolin- and clathrin-independent entry of BKPyV into primary human proximal tubule epithelial cellsIn Vitro Replication Assay for Merkel Cell Polyomavirus (MCPyV).Effect of Leflunomide, Cidofovir and Ciprofloxacin on replication of BKPyV in a salivary gland in vitro culture system.Role of cell-type-specific endoplasmic reticulum-associated degradation in polyomavirus trafficking.BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies.Identification of Rab18 as an Essential Host Factor for BK Polyomavirus Infection Using a Whole-Genome RNA Interference Screen.Rhodiolae Kirliowii Radix et Rhizoma and Crataegus pinnatifida Fructus Extracts Effectively Inhibit BK Virus and JC Virus Infection of Host Cells.BK Virus Nephropathy: Histological Evolution by Sequential Pathology.BK Virus and Nephropathy in Kidney Transplant Recipients.Immunohistochemistry Is Rarely Justified for the Diagnosis of Viral Infections.The first case of acute unilateral pan-ureteritis caused by BK polyomavirus in an allogeneic stem cell transplant patient.BK Virus-Associated Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplantation in the Pediatric Population.Polyomavirus nephropathy of the native kidney in a patient with rheumatoid arthritis and pulmonary fibrosis.Conversion to a sirolimus-based regimen is associated with lower incidence of BK viremia in low-risk kidney transplant recipients.Currently recommended BK virus (BKV) plasma viral load cutoff of ≥4 log10/mL underestimates the diagnosis of BKV-associated nephropathy: a single transplant center experience.Test performance characteristics of quantitative nucleic acid testing for polyomaviruses in kidney and kidney-pancreas transplant recipients.Neutralizing Antibody-Mediated Response and Risk of BK Virus-Associated Nephropathy.Impact of low-level BK polyomavirus viremia on intermediate-term renal allograft function.The Banff Working Group Classification of Definitive Polyomavirus Nephropathy: Morphologic Definitions and Clinical Correlations.Precision Transplant Medicine: Biomarkers to the Rescue.The time dependency of renal allograft histology.Pathology of resolving polyomavirus-associated nephropathy.Agnoprotein Is an Essential Egress Factor during BK Polyomavirus Infection.
P2860
Q21231951-DCEDAB9E-4CEF-4EDA-B84D-B9445664DB06Q21285083-D4D6F3A0-9AA5-4B9E-A0E3-A9248677D1B7Q33643453-9B0F522B-036E-4C72-8799-7E7BA7025C6CQ34259801-93A8976F-06A4-42AE-90F9-1B413726E5A6Q34332024-108A6BB4-0AC7-4A18-8061-044FFC312163Q35006676-3CE94A6C-C463-4683-989B-95F001B33E03Q35886711-A4B8C55F-A820-4A31-8396-1D6A10D09E1EQ36297604-AEFF4012-6A66-40F6-A4B6-73A9F9CCFE71Q36782695-CEA0C79A-381A-4764-B78B-1783054E15A9Q37155134-02FE5A46-AEF6-40D2-883B-7F6C5A093612Q37260167-5B8E27D1-6A6E-4DEE-AB21-7B71E5B91A4FQ37340200-A3548EA5-E538-4D47-AB0F-D5538E30E9C9Q37345783-288DF4BC-E6C2-41D1-A4B1-BAE37785BF5EQ38323818-34E0BB0A-6B7C-4101-BE53-E24FA3A7D248Q38723077-C30FF368-652B-405C-BD0F-BEF2DD57B1E3Q38792000-018E7C69-C3A0-445C-BAA6-D8E64950B172Q38847050-242F7C10-5FFA-44BA-A6C5-2D36A5E5377EQ39103226-BC480988-6BA5-4EF7-B5ED-B7D1A8D37D53Q39143376-20EDE6A0-6D64-4758-A7B4-7E395A643DE2Q39180715-D9A10CD9-ECBA-48CB-84AB-5B56D7E0586DQ40080609-79780354-5E64-4A49-9BA6-D0D78CA1CB61Q40101970-C4B71D33-7A4C-4F62-9D75-45BAB0DBECFAQ40260844-DDD6C51A-B0C9-4280-912E-7C2BFB8FDC64Q40384766-988556BB-6FCC-4B0F-9A5E-137EA66CD10CQ40398302-E28D5FAA-47BD-4487-82D0-99645962816AQ40815422-D8FADA83-C3C4-4C76-8213-7598FF541F76Q40895043-EDA692DB-7F46-40CD-A853-3FAA21A005AEQ41027408-C40F192B-08D4-44A5-89FE-F8929C05C949Q41548443-D4F064C7-31EA-4C84-BDD3-849E644092D3Q42252631-BE7BF374-ECA7-4DF1-BCDB-ABC6029F8BCBQ42276202-61B373E5-DCE9-4D64-8DBC-505B3B295F2DQ45326184-D82F8C19-B0C8-47C9-8D85-5ECF381C56FAQ47212150-96CF4529-6868-4EEC-82B8-9EFCEC1B7F7DQ47246603-696EA8B2-DD07-437A-9942-7F1075FC726CQ47656083-602E1004-8928-46C4-975C-8BB66AE3B4C3Q48162490-8A2D189B-60B9-45F8-BB44-5D09A907387FQ51873284-4A0662C9-ECF0-492A-83AC-F15B79E0D77BQ52644498-7F9D5048-804A-4FBB-92A7-C76A1B7DF1F6
P2860
Management of polyomavirus-associated nephropathy in renal transplant recipients.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Management of polyomavirus-associated nephropathy in renal transplant recipients.
@en
type
label
Management of polyomavirus-associated nephropathy in renal transplant recipients.
@en
prefLabel
Management of polyomavirus-associated nephropathy in renal transplant recipients.
@en
P2860
P356
P1476
Management of polyomavirus-associated nephropathy in renal transplant recipients.
@en
P2093
Dirk R J Kuypers
P2860
P2888
P304
P356
10.1038/NRNEPH.2012.64
P407
P577
2012-04-17T00:00:00Z
P5875
P6179
1002594882